HSGX - Histogenics Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 520.81M
Enterprise Value 318.03M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.91

Trading Information

Stock Price History

Beta (3Y Monthly) 3.94
52-Week Change 3-63.13%
S&P500 52-Week Change 32.99%
52 Week High 31.4300
52 Week Low 30.0800
50-Day Moving Average 30.2157
200-Day Moving Average 30.1880

Share Statistics

Avg Vol (3 month) 35.82M
Avg Vol (10 day) 37.92M
Shares Outstanding 594.6M
Float 83.53M
% Held by Insiders 16.44%
% Held by Institutions 110.94%
Shares Short (Aug 15, 2019) 47.35M
Short Ratio (Aug 15, 2019) 42.02
Short % of Float (Aug 15, 2019) 48.27%
Short % of Shares Outstanding (Aug 15, 2019) 47.77%
Shares Short (prior month Jul 15, 2019) 44.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-136.46%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -19.79M
Net Income Avi to Common (ttm)-3.02M
Diluted EPS (ttm)-0.3570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.79M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.05
Book Value Per Share (mrq)-0.09

Cash Flow Statement

Operating Cash Flow (ttm)-25.4M
Levered Free Cash Flow (ttm)-21M